On January 10, 2022, Thorne HealthTech, Inc. entered into an agreement with Mitsui & Co. Ltd. and TM HealthTech Pte. Ltd. to form a joint venture entity to be named Thorne HealthTech Asia PTE, LTD to exclusively market, distribute and sell Thorne's products across Singapore, Hong Kong, Taiwan, Thailand, Indonesia, Malaysia, Australia, the Philippines, Vietnam, India, and New Zealand.

Upon formation of the Joint Venture, Thorne and Mitsui will hold 51% and 49%, respectively, of the total issued share capital of the Joint Venture. In conjunction with the formation and operation of the Joint Venture, Thorne and Mitsui have agreed to initially contribute approximately $2.7 million and $2.6 million, respectively.